We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Merck won a key court victory late Tuesday with a jury concluding that two of Gilead Science’s blockbuster drugs infringe patents held by Merck & Co. and Ionis Pharmaceuticals. Read More
Health insurer Anthem is suing Express Scripts in federal court for nearly $15 billion, claiming that the PBM has overcharged and is refusing to renegotiate future drug prices. Read More
The FDA put a damper on Eagle Pharmaceuticals’ plans to market its blood thinner Kangio via a complete response letter not recommending approval. Read More
An ex-Turing executive took his former employer to task on Thursday, telling lawmakers the drugmaker’s decision to raise the price of Daraprim by 5,000 percent was “unjustified.” Read More
A jury sided with Amgen Wednesday in a suit accusing Regeneron and Sanofi of violating two of its patents when they developed a cholesterol-fighting biologic. Read More
Prescription drug prices rose 5.2 percent for customers of PBM Express Scripts in 2015, approximately half of the increase seen in 2014, the company stated Tuesday in its annual Drug Trend report. Read More